Comprehensive Treatment for Tardive Dyskinesia
2023 Neurological Disease Working Group Meeting Summary
First Alzheimer’s Agitation Drug Could Help Patients, Caregivers
Why We Don’t Understand Parkinson’s in Black Americans
Policymakers Called to Tackle Telehealth Reform
Fight Continues to Expand Federal Benefits for Huntington’s Disease
Making Migraine Treatment Accessible
Alliance for Patient Access
Huntington’s Disease: The Need for a Cure
FDA Grants Priority Review to Drug for Depressive Disorders
Overburdened by Alzheimer’s: The Need for Care, Innovation and Access
